See editorial on page 149.

SummaryWe identified that interferon-λ3 promotes intestinal epithelial cell defense against *Cryptosporidium parvum* by inhibiting parasite invasion and mitigating loss of paracellular barrier function. These findings may lead to novel therapeutic targets by which *C parvum* clearance can be promoted.

Cryptosporidiosis causes unrelenting diarrhea in immunocompromised individuals worldwide and is the most common cause of infectious water and foodborne diarrheal outbreaks in the United States, resulting in an estimated 750,000 cases each year.[@bib1] In developing countries, *Cryptosporidium* species is the second leading cause of infectious diarrheal death in children younger than the age of 5 years and results in approximately 200,000 deaths annually.[@bib2], [@bib3]

*Cryptosporidium* infection occurs by fecal--oral transmission of environmentally resistant oocysts. After ingestion, oocysts release infective sporozoites that attach and become enveloped in the apical membrane of small intestinal villus intestinal epithelial cells (IECs) where they complete a complex and recurring life cycle. When *Cryptosporidium* infects the villus epithelial cells, they are shed rapidly, resulting in profound villus blunting. In this condition, nutrient malabsorption, intestinal secretion, and failure of barrier function result in severe diarrhea, dehydration, starvation, and, frequently, death. Despite decades of research, there are currently no consistently effective treatments for cryptosporidiosis. Clearance of the pathogen and recovery from infection are reliant on a competent host response and access to supportive care. The use of more insightful therapies to promote recovery of individuals with cryptosporidiosis is hindered by a lack of understanding of how the intestinal epithelium favorably combats the infection.

To address this gap in understanding, we began our study by investigating the transcriptional response of *C parvum*--infected IECs in a robust model of cryptosporidiosis, the neonatal piglet. We hypothesized that the IEC transcriptional signature would provide clues that would aid in identifying novel epithelial-derived mechanisms of innate immune activation and host defense against *C parvum* infection. Accordingly, we detected that IECs up-regulate numerous interferon (IFN)-stimulated genes during peak *Cryptosporidium* infection. By investigating the specific stimulus for this IFN response, we identified that *C parvum* infection induces robust mucosal expression of a type III IFN: IFN-λ3.[@bib4], [@bib5]

There is mounting evidence that IFN-λ is a critical mediator for the innate protection of epithelia against viral infection.[@bib6], [@bib7] In addition, IFN-λ has shown extraintestinal epithelial barrier--protective effects in the face of viral infection.[@bib8] However, to date, the role of IFN-λ in defense against nonviral enteric diarrheal pathogens or in the promotion of intestinal epithelial barrier function has been limited to a single study.[@bib9] Accordingly, the aim of this study was to determine the significance of IFN-λ expression to epithelial defense and barrier function during *C parvum* infection.

Results {#sec1}
=======

The Intestinal Epithelial Transcriptional Response to *C parvum* Infection In Vivo Is Dominated by Targets of Interferon Signaling {#sec1.1}
----------------------------------------------------------------------------------------------------------------------------------

Our understanding of host strategy for epithelial defense against infection by *C parvum* remains poorly understood. In an effort to distinctively characterize the innate response of the intestinal epithelium to *C parvum* infection we used a host species that fully reproduces the diarrheal disease as observed in children with cryptosporidiosis.[@bib10] Accordingly, we infected neonatal piglets with *C parvum* and harvested the ileal epithelium at peak infection (days 3--5) for microarray analysis of the IEC transcriptional response. Piglets that were selected had a heavy burden of infection (57% ± 8.0% of villus enterocytes harbored *C parvum*) and showed marked villus blunting when compared with control piglets (*P* = .004) ([Figure 1](#fig1){ref-type="fig"}*A* and *B*). Based on the microarray analysis, 61 genes were up-regulated significantly and 20 genes were down-regulated significantly in IECs from *C parvum*--infected compared with control piglets ([Figure 1](#fig1){ref-type="fig"}*C* and *D*). Gene ontology analysis identified the IFN signaling pathway (*P* \< .001) as the most enriched biological process in IECs from infected piglets. Twelve (20%) of the 61 significantly up-regulated genes were identified as targets of IFN signaling; specifically interferon-stimulated gene 15 (*ISG15*), guanylate binding protein 1 and 2 (*GBP1* and *GBP2*), proteasome subunit-β type 8, interferon-α inducible protein 27, interferon stimulated gene-20, calcium-binding and coiled-coil domain-2, interferon-induced protein 44-like, tripartite motif containing 34, ubiquitin D, placenta-specific gene 8, and ribonuclease 4. The gene identified as most highly expressed in response to *C parvum* infection was *ISG15* (21-fold). Significantly increased mucosal expression of *ISG15* messenger RNA (mRNA) in vivo additionally was confirmed by targeted quantitative polymerase chain reaction (PCR) ([Figure 1](#fig1){ref-type="fig"}*E*). To further localize cellular *ISG15* expression in the context of the entire ileum mucosa, fluorescence in situ hybridization was performed on uninfected control and *C parvum*--infected piglet ileum using custom-designed oligonucleotide probes specific for porcine *ISG15*. *ISG15* mRNA was expressed predominately in the villus intestinal epithelial cells in infected piglets ([Figure 1](#fig1){ref-type="fig"}*F*).Figure 1**IECs up-regulate numerous ISGs in response to *C parvum* infection.** Intestinal epithelium was harvested from ileum mucosa of neonatal piglets at the time of peak infection (days 3--5 after infection) (n = 8) and from age-matched uninfected controls (n = 4) for performance of gene expression analysis using microarrays. (*A*) Representative photomicrograph of ileum mucosa from an uninfected control and *C parvum*--infected piglet used for microarray analysis. H&E stain. *Scale bar*: 20 μm. (*B*) Villus height and crypt depth (μm) and the percentage of total villus IECs that were infected with *C parvum* in control (n = 4) and *C parvum*--infected (n = 8) piglets used for microarray analysis. Each data point represents the average of 5 measurements per piglet. *Scale bars*: means ± SD. \*\**P* \< .01, Student *t* test comparison between uninfected and *C parvum*--infected piglets. Heat map of significantly (*C*) up-regulated and (*D*) down-regulated genes in infected (*C parvum*) and control (Uninf) exfoliated ileum villus epithelial cells. Each control and infected biological replicate is represented. Gene IDs:fold change are listed to the right of the heat map. Known ISGs are highlighted in red. (*E*) qRT-PCR analysis of porcine ileum mucosal total cellular mRNA for the presence of *ISG15* mRNA. Samples were obtained from piglets used for microarray analysis at peak *C parvum* infection (days 3--5, n = 5) and age-matched controls (n = 5). For each sample, the Ct value for *ISG15* was normalized to expression of the housekeeping gene *cyclophilin* (ΔCt). Fold-change differences between each sample were compared with a representative uninfected sample using the 2^-ΔΔCt^ method. *Scale bars*: means ± SD. \*\**P* \< .01, Student *t* test comparison between uninfected and *C parvum*--infected piglets. (*F*) Fluorescence in situ hybridization showing *ISG15* mRNA (red fluorescence) in villus epithelial cells of ileum mucosa from piglets at peak *C parvum* infection and absent in villus epithelium of control piglets. Photomicrograph representative of results of 2 independent experiments. *Scale bar*: 50 μm.

*Intestinal Mucosal Expression* {#sec1.2}
-------------------------------

Having identified that targets of IFN signaling constitute a major transcriptional response of the intestinal epithelium to *C parvum* infection, we sought to determine what type(s) of IFN were likely stimulating this response in vivo. Accordingly, we used our own and published primers to quantify, by means of quantitative reverse-transcription PCR (qRT-PCR), specific members of all 3 classes of IFN (types I--III) using RNA extracted from the ileum mucosa ([Figure 2](#fig2){ref-type="fig"}*A*). There was no difference in expression of type I IFN (ie, *IFN-α* and *IFN-β*) observed between ileum mucosa of uninfected control and *C parvum*--infected piglets. Type II IFN (*IFN-γ*) expression was up-regulated approximately 20-fold. However, type III IFN, specifically *IFN-λ3*, was increased more than 200-fold in the ileum mucosa of infected piglets.Figure 2***C parvum* stimulates ileum mucosal expression of IFN-λ3 in piglets and this response is conserved in neonatal mice.** (*A*) qRT-PCR analysis of porcine ileum mucosal total cellular mRNA for the presence of *IFN-α* (all isoforms, 7/11, and 9), *IFN-β*, *IFN-γ*, and *IFN-λ 1, 3, and 4*. Samples were obtained from piglets at peak *C parvum* infection (days 3--5, n = 6--11) and age-matched controls (n = 5--7). Infected piglets showed significantly increased expression of both *IFN-λ3* (∼200-fold) and *IFN-γ* mRNA (∼20-fold). Results obtained from 2 independent experiments were combined. \**P* \< .05, Kruskal--Wallis analysis of variance comparison between uninfected and *C parvum*--infected piglets. *IFN-λ4* was not amplified from any samples. For each sample, the Ct for IFN expression was normalized to expression of the housekeeping gene cyclophilin (ΔCt). For each IFN type, fold-change differences between samples are expressed as compared with a representative uninfected sample using the 2^-ΔΔCt^ method. *Bars* represent means ± SD. (*B--F*) Characterization of a 10-day time course of *C parvum* infection in suckling C57BL/6 pups after orogastric gavage of 2 × 10^5^*C parvum* oocysts or mock infection with PBS. Sampling took place on days 3--6, and day 10 after infection. (*B*) qRT-PCR analysis of *Cryptosporidium* glycoprotein 40/15 mRNA in total distal colon for quantification of fecal shedding of *C parvum*. All data points represent a fold-change comparison of individual pups with a representative day 3 infected pup. *Bars* represent means ± SD. (*C*) The average number of epithelium-associated *C parvum* per 10 villi per pup by light microscopy. *Bars* represent means ± SD. (*D* and *E*) Villus height and crypt depth as averaged for 10 villus crypt units per pup. *Bars* represent means ± SD. \**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001, Student *t* test compared with uninfected pups at the same time point. (*F*) qRT-PCR analysis of IFN-λ2/3 and ISG15 mRNA expression in samples of total ileum mucosa from control and infected pups at peak infection (days 4--6). For each sample, the Ct value for gene expression was normalized to expression of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (ΔCt). For each gene, fold-change differences between uninfected and *C parvum*--infected samples are expressed as compared with a representative uninfected sample using the 2^-ΔΔCt^ method. *Bars* represent means ± SD. \**P* \< .05, Student *t* test compared with uninfected pups. Each panel combines results obtained from 2 independent experiments.

A Type III Interferon Response Is Conserved in Suckling Mice Infected With *C parvum* {#sec1.3}
-------------------------------------------------------------------------------------

To further investigate the mechanistic relationship between *C parvum* infection, transcription of *IFN-λ3*, and increased expression of IFN-stimulated genes by the intestinal epithelium in vivo, we first sought to establish whether these observations were conserved in a mouse model. For these studies we used wild-type neonatal suckling mice because of their innate susceptibility to infection and its associated intestinal pathology. Over a 10-day time-course of infection, wild-type pups showed peaks in colonic content of *C parvum* mRNA, ileum IEC-associated *C parvum* organisms, and histologic indices of intestinal injury (villus blunting and crypt elongation) between 4 and 6 days after infection, with clearance typically occurring by day 10 ([Figure 2](#fig2){ref-type="fig"}*B--E*). At peak infection, the expression of IFN-λ2/3 and *ISG15* mRNA were increased significantly in total distal jejunum/proximal ileum samples from *C parvum*--infected compared with uninfected mouse pups ([Figure 2](#fig2){ref-type="fig"}*F*).

Immunoneutralization of IFN-λ2/3 Increases Severity of Epithelial Infection and Mucosal Injury in Suckling Mice Infected With *C parvum* {#sec1.4}
----------------------------------------------------------------------------------------------------------------------------------------

To determine the impact of IFN-λ2/3 on host defense against *C parvum* infection, neonatal mouse pups were treated parenterally with human anti-mouse IFN-λ2/3 immunoneutralizing vs isotype control antibodies on days --1, 0, and 3 of *C parvum* infection. As assessed at the time of peak infection (days 4--6), pups treated with anti--IFN-λ2/3 antibodies had a significantly greater number of organisms infecting the villus IEC ([Figure 3](#fig3){ref-type="fig"}*A*) and were more likely to shed *C parvum* in feces (19 of 20; 95%) compared with pups treated with isotype control antibodies (13 of 19; 68%), although the quantity of *C parvum* shed in the feces was similar between the treatment groups ([Figure 3](#fig3){ref-type="fig"}*B*). When examined during the recovery stage of infection (day 10), pups treated with anti--IFN-λ2/3 antibodies had retained greater numbers of organisms infecting the villous epithelium ([Figure 3](#fig3){ref-type="fig"}*C*) and continued to shed *C parvum* in feces and in significantly greater quantities compared with mice treated with isotype control antibodies ([Figure 3](#fig3){ref-type="fig"}*D*). In addition to a more severe epithelial burden and prolonged fecal shedding of *C parvum*, pups treated with anti--IFN-λ2/3 antibodies had quantitatively greater villus blunting and crypt elongation compared with infected pups treated with only the isotype control antibody ([Figure 3](#fig3){ref-type="fig"}*E--G*).Figure 3**Immunoneutralization of IFN-λ exacerbates *C parvum* infection.** Mice were treated with either 15 μg of rat isotype or rat--anti-mouse IFN-λ2/3 neutralizing antibodies on days -1, 0, and 3 after orogastric gavage of *C parvum* or mock infection with PBS. (*A*) Quantitative assessment of *C parvum* epithelial burden at time of peak infection (days 4--6). Data points represent the average number of epithelium-associated *C parvum* per 10 villi per individual pup by light microscopy. *Lines* represent means ± SD. \**P* \< .05, Student *t* test comparing isotype control with anti--IFN-λ--treated pups. (*B*) Colonic content of *C parvum* of individual pups at peak (days 4--6) infection as determined by qRT-PCR analysis of *Cryptosporidium* gp40/15 mRNA. For each sample, the Ct value for gene expression was normalized to expression of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (ΔCt). Fold-change differences between isotype and anti--IFN-λ--treated pups are expressed as compared with a representative isotype-treated pup using the 2^-ΔΔCt^ method. *Lines* represent means ± SD. ^δ^*P* \< .05, chi-square test comparing the percentage of pups shedding *C parvum* between isotype and anti--IFN-λ--treated groups. (*C*) Quantitative assessment of *C parvum* epithelial burden at late stage (day 10) of infection. Data points represent the average number of epithelium-associated *C parvum* per 10 villi per individual pup by light microscopy. *Lines* represent means ± SD. ^δ^*P* \< .05, chi-square test comparing the percentage of pups with epithelial organisms between isotype and anti--IFN-λ--treated groups. (*D*) Colonic content of *C parvum* of individual pups at late stage (day 10) of infection as determined by qRT-PCR analysis of *Cryptosporidium* gp40/15 mRNA. Fold-change analysis as described for panel *B*. \**P* \< .05, Student *t* test comparing isotype control with anti--IFN-λ--treated pups. (*E*) Average villus height and (*F*) crypt depth for 10 villus crypt units per individual pups at peak infection (\**P* \< .05, Student *t* test comparing isotype control with anti--IFN-λ--treated pups.). *Lines* represent means ± SD. (*A--F*) Results obtained from 2 independent experiments were combined experiments. (*G*) Representative photomicrographs of uninfected control and *C parvum*--infected ileum mucosa obtained on day 6 after infection from mouse pups treated with rat isotype or rat--anti--IFN-λ2/3 neutralizing antibodies. *Arrows* highlight *C parvum*--infecting IECs. *Scale bar*: 20 μm for *top* and *middle rows*, and 10 μm for *bottom row*.

Intestinal Epithelial Cells Are Sufficient to Serve as a Source of IFN-λ and IFN-β and Autonomously Mediate an Interferon Response to *C parvum* Infection {#sec1.5}
----------------------------------------------------------------------------------------------------------------------------------------------------------

Having shown a significant and specific influence of IFN-λ in promoting intestinal defense against *C parvum* in immunoneutralized mouse pups, we sought to next determine the direct involvement of the intestinal epithelium in mediating the IFN response to infection. These studies were performed using a nontransformed porcine-derived small intestinal epithelial cell line (IPEC-J2) as a reductionist model for comparative studies with the neonatal piglets. We first confirmed that IPEC-J2 cells constitutively express IFN-λR1 mRNA by means of RT-PCR ([Figure 4](#fig4){ref-type="fig"}*A*). We subsequently examined the functionality of the receptor to stimulation using recombinant human IFN-λ3 (rHuIFN-λ3). Treatment of polarized IPEC-J2 cell monolayers with rHuIFN-λ3 resulted in a dose- and time-dependent induction of *ISG15* mRNA expression that peaked at a concentration of 1000 U/mL at 24 hours after stimulation ([Figure 4](#fig4){ref-type="fig"}*B*). Other studies have shown that epithelial cells express IFN-λ in response to viral infection,[@bib6], [@bib7] however, few studies have examined whether or not this response occurs with nonviral pathogens.[@bib11], [@bib12], [@bib13] To determine if *C parvum* infection is sufficient to induce a type III IFN response by the intestinal epithelium, we infected polarized monolayers of IPEC-J2 cells with *C parvum* and quantified the expression of *IFN-λ3* and *ISG15* mRNA over a 48-hour time course using qRT-PCR. The burden of *C parvum* infection oscillated over time within the monolayers, reflective of the phasic nature of the life cycle,[@bib14] and was accompanied by a significant decrease in transepithelial electrical resistance (TEER) beginning at 24 hours after infection ([Figure 4](#fig4){ref-type="fig"}*C* and *D*). The epithelial infection was associated with a significant increase in expression of *IFN-λ3* mRNA beginning at 24 hours followed by a significant increase in expression of *ISG15* mRNA beginning at 36 hours after infection ([Figure 4](#fig4){ref-type="fig"}*E* and *F*). To determine if *C parvum* stimulated the expression of other types of IFN that also could contribute to the observed *ISG15* response, qRT-PCR also was used to quantify types I and II IFN ([Figure 5](#fig5){ref-type="fig"}). Apart from *IFN-λ3*, significant increases in expression also were observed for *IFN-β* beginning 24 hours after infection. Significant increases in expression of *IFN-α* were not observed at any time point after infection, despite the use of published primer pairs designed to amplify all of the known isoforms of porcine *IFN-α*.[@bib15] Amplification of *IFN-γ* was not observed in either control or *C parvum*--infected IPEC-J2 cells at any time point.Figure 4***C parvum* is sufficient to stimulate IEC expression of IFN-λ3 and ISG15 mRNA.** (*A*) Amplicons generated after PCR amplification of IFN-λR1 (249 bp) using porcine genomic DNA (lane 1), cDNA prepared from IPEC-J2 cell mRNA (lane 2), and cDNA prepared from porcine ileum mucosa mRNA (lane 3) as template. (*B*) qRT-PCR analysis of *ISG15* mRNA expression by individual IPEC-J2 cell monolayers at time points of 6, 12, 24, or 48 hours after stimulation with rHuIFN-λ3 (100 or 1000 U/mL) or vehicle (0.1% bovine serum albumin in PBS). *Bars* represent means ± SD. For each monolayer, the Ct value for *ISG15* gene expression was normalized to expression of the housekeeping gene cyclophilin (ΔCt). For each treatment group, fold-change differences at each time point are expressed as compared with a representative monolayer at t = 6 hours using the 2^-ΔΔCt^ method. Figure combines results obtained from 2 independent experiments. (*C*) Measurement of infection burden over time on the basis of qRT-PCR analysis of *Cryptosporidium* glycoprotein 40/15 mRNA in infected IPEC-J2 monolayers (n = 4 unique monolayers at each time point). For each monolayer, the Ct value for gene expression was normalized to expression of the housekeeping gene cyclophilin (ΔCt). For each time point, fold-change differences between monolayers were expressed relative to a representative 6-hour infected monolayer using the 2^-ΔΔCt^ method. *Bars* represent means ± SD. Data representative of 2 independent experiments. (*D*) TEER of control and infected IPEC-J2 monolayers (n = 4 each) expressed as a percentage of each individual monolayer's TEER at time = 0. *Bars* represent means ± SD. \**P* \< .05, \*\*\**P* \< .001, Student *t* test comparing uninfected with *C parvum*--infected monolayers at the same time point. Data are representative of 2 independent experiments. (*E* and *F*) qRT-PCR analysis of *IFN-λ3* and *ISG15* mRNA expression from control and *C parvum*--infected IPEC-J2 monolayers (n = 8 monolayers per treatment group per time point). For each monolayer, the Ct value for target gene expression was normalized to expression of the housekeeping gene cyclophilin (ΔCt). For each time point, fold-change differences between uninfected and infected monolayers are expressed as compared with a representative uninfected monolayer using the 2^-ΔΔCt^ method. *Bars* represent means ± SD. \**P* \< .05, \*\**P* \< .01, and \*\*\**P* \< .001, Student *t* test comparing uninfected with *C parvum*--infected monolayers at the same time point. (*E* and *F*) Results obtained from 2 independent experiments have been combined. MW, molecular weight.Figure 5**IEC (IPEC-J2) monolayers express IFN-β but not IFN-α mRNA in response to *C parvum* infection.** qRT-PCR analysis of (*A*) *IFN-α* (all) isotypes, (*B*) *IFN-α7/11* isotypes, (*C*) *IFN-α9* isotype, and (*D*) *IFN-β* during a 48-hour time course of *C parvum* infection in IPEC-J2 cells. N = 4 monolayers per treatment group and time point. For each monolayer, the Ct for target gene expression was normalized to expression of the housekeeping gene *cyclophilin* (ΔCt). Fold-change differences between uninfected and infected monolayers are expressed as compared with a representative uninfected monolayer at the same time point using the 2^-ΔΔCt^ method. *Bars* represent means ± SD. \**P* \< .05, \*\**P* \< .01, Student *t* test comparison between uninfected and infected monolayers at same time point. Results were obtained from 1 independent experiment.

Intestinal Epithelial Cells Primed With IFN-λ3 Have Enhanced Resistance to *C parvum* Infection and Improved Barrier Function {#sec1.6}
-----------------------------------------------------------------------------------------------------------------------------

To determine if the intestinal epithelium is sufficient to mediate the anticryptosporidial and mucosal protective effects of IFN-λ, as observed to be impaired in immunoneutralized mice, we primed intestinal epithelial monolayers with rHuIFN-λ3 for 12 hours before introduction of *C parvum*, thereby enabling the peak IFN response (eg, *ISG15* up-regulation) to coincide with establishment of cellular *C parvum* infection (12--24 hours after infection). A dose-response increase in *ISG15* mRNA expression was observed in *C parvum*--infected intestinal epithelial monolayers that were primed with exogenous rHuIFN-λ3 (range, 100--2500 U/mL) ([Figure 6](#fig6){ref-type="fig"}*A*). Priming of monolayers with rHuIFN-λ3 was accompanied by correspondingly significant inhibitory effects on *C parvum* infection burden ([Figure 6](#fig6){ref-type="fig"}*B*). The percentage of inhibition of *C parvum* burden was correlated positively to up-regulation of *ISG15* expression (Pearson correlation coefficient R = 0.574, *P* = .0082). In addition to promoting epithelial defense against infection, rHuIFN-λ3 priming significantly abrogated *C parvum*--associated loss of TEER at concentrations ranging from 100 to 1000 U/mL. This barrier protective effect waned, for unknown reasons, in cells treated with a higher dose of rHuIFN-λ3 (ie, 2500 U/mL) and was not observed in monolayers not infected with *C parvum* ([Figure 6](#fig6){ref-type="fig"}*C*). Importantly, neither *C parvum* nor rHuIFN-λ3 alone, or in combination, resulted in a loss of epithelial cells from treated monolayers ([Figure 6](#fig6){ref-type="fig"}*D* and *E*), suggesting that IFN-λ3 enhanced defense against *C parvum* using effector mechanisms contained within the intact monolayer.Figure 6**Priming of IECs with exogenous IFN-λ3 decreases the burden of *C parvum* infection, abrogates loss of TEER, and enhances resistance to *C parvum* invasion.** Polarized monolayers of IPEC-J2 cells were pretreated with either vehicle, or 100, 500, 1000, or 2500 U/mL of rHuIFN-λ3 for 12 hours before *C parvum* infection. At the time of peak *C parvum* infection (12--24 hours after infection) the effect of rHuIFN-λ3 was assessed by qRT-PCR analysis of (*A*) ISG15 mRNA expression, (*B*) *Cryptosporidiumgp40*/15 mRNA content, and by (*C*) measurement of TEER. The Ct for *ISG15* and *Cryptosporidiumgp40/15* mRNA content of each monolayer was normalized to expression of the housekeeping gene cyclophilin (ΔCt). For each treatment group, fold-change differences in *ISG15* and *Cryptosporidiumgp40/15* were expressed as compared with a (A) representative uninfected monolayer or a (*B*) representative infected monolayer, respectively, using the 2^-ΔΔCt^ method. \*\**P* \< .01, \*\*\**P* \< .001, 1-way analysis of variance comparison between treatment groups and (*A*) uninfected or (*B*) infected monolayers. For TEER (*C*), individual data points are expressed as a percentage of a representative uninfected monolayer. \**P* \< .05, \*\**P* \< .01, 1-way analysis of variance comparison between treatment groups and uninfected monolayers. *Bars* represent means ± SD. (*A--D*) Results were obtained from 2 independent experiments and combined. (*D*) Spectrophotometric assay of crystal violet absorbance (570 nm) by IPEC-J2 monolayers after a 48-hour time course of *C parvum* infection. N = 6 monolayers per treatment and time group. Figure contains results obtained from 1 experiment. (*E*) Spectrophotometric assay of crystal violet absorbance in individual uninfected control and *C parvum*--infected monolayers 24 hours after infection and in monolayers primed with 1000 U/mL of rHuIFN-λ3 12 hours before the infection. Figure combines results obtained from 2 independent experiments. *Bars* represent means ± SD. (*F*) Intestinal epithelial (IPEC-J2) monolayers were grown on chamber slides and pretreated with either vehicle (n = 15 monolayers) or 1000 U/mL of rHuIFN-λ3 (n = 15 monolayers) for 12 hours before a 48-hour time course of *C parvum* infection. Three monolayers from each treatment group were examined using fluorescence microscopy at 4, 6, 12, 24, and 48 hours after infection, at which times quantification of invading *C parvum* parasites was determined by counting the total number of FITC--*C parvum* and Alexa-555 phalloidin co-labeled parasites within ten 400× fields per monolayer. At each time point, data compare the percentage reduction in *C parvum* invasion observed in 3 individual rHuIFN-λ3--treated monolayers compared with the average *C parvum* invasion observed in 3 individual vehicle-treated monolayers. *Bars* represent means ± SD. Figure contains results obtained from 1 experiment. (*G*) Representative fluorescence microscopy images of *C parvum* asexual intracellular life stages. Parasites shown reflect positive labeling with FITC--*C parvum* (green), DAPI-positive *C parvum* nuclei (blue and indicated by *arrows*), and Alexa-555--phalloidin cellular invasion sites (red). *Scale bar*: 1 μm. (*H*) The relative percentage of *C parvum* asexual life stages at each time point in vehicle-treated (*left*) and rHuIFN-λ3--pretreated infected monolayers. Parasite life stages were counted and classified within five 1000× fields for each monolayer. Data represent an average of n = 3 monolayers per time and treatment group. \*\**P* \< .01, chi-square comparison of the percentage of trophozoites with vehicle-treated monolayers at the same time point.

Interferon-λ3 Decreases *C parvum* Invasion of IECs and Disrupts Early Intracellular Development {#sec1.7}
------------------------------------------------------------------------------------------------

To gain additional insight into the cell-based mechanism(s) by which IFN-λ3 promotes epithelial defense against *C parvum* infection, we quantified the influence of rHuIFN-λ3 priming (1000 U/mL) on subsequent parasite invasion and cell-associated development. For these studies, infected epithelial monolayers were treated with a fluorescein isothiocyanate (FITC)-labeled anti-*Cryptosporidium* species antibody and counterstained with 4′,6-diamidino-2-phenylindole (DAPI). Recruitment of host--F-actin to cell-associated *Cryptosporidium* species[@bib16], [@bib17] organisms was used to identify host--parasite invasion sites and the associated intracellular life stages were identified on the basis of organism size and the number of nuclei. Inhibitory effects of rHuIFN-λ3 on visualized *C parvum* invasion occurred within 12 hours of infection ([Figure 6](#fig6){ref-type="fig"}*F*). The magnitude of inhibition of *C parvum* invasion was similar to earlier indirect measurements of infection burden based on qRT-PCR for *C parvum* glycoprotein 40/15 (gp40/15) after priming of IPEC-J2 cells with rHuIFN-λ3 ([Figure 6](#fig6){ref-type="fig"}*B*). In unprimed cells, *C parvum* was observed to develop through an orderly progression of intracellular life stages over 48 hours. However, in rHuIFN-λ3--primed cells, a delay in maturation of *C parvum* was observed as early as 6 hours after infection with persistence of sporozoites and early trophozoites within the monolayers ([Figure 6](#fig6){ref-type="fig"}*G* and *H*). By 12 hours after infection, rHuIFN-λ3--primed monolayers resumed a distribution of life stages similar to unprimed cells but with 30% less parasites, suggesting loss of developmentally delayed sporozoites and early trophozoites from rHuIFN-λ3--treated monolayers.

Interferon-λ3 Mitigates Loss of Barrier Function by Decreasing Paracellular Sodium Conductance of *C parvum*--Infected Epithelium {#sec1.8}
---------------------------------------------------------------------------------------------------------------------------------

To further characterize the mechanism by which priming of epithelial monolayers with rHuIFN-λ3 ameliorates subsequent loss of TEER associated with *C parvum* infection, we conducted studies to define the nature of the barrier function defect. Having established, by means of crystal violet retention, that decreases in TEER were not associated with loss of cells from the monolayer, we focused on examination of the leak, pore, and ion/charge selective pathways, which are governed by the modification of tight junctional proteins.[@bib18], [@bib19], [@bib20], [@bib21] Accordingly, we probed the pathway by which *C parvum* and IFN-λ3 influence barrier function by measuring the transepithelial flux of 70-kilodalton dextran, 4-kilodalton dextran, creatinine, and ^22^Na^+^. At the time of peak *C parvum*--induced decreases in TEER, there was no significant difference in the transepithelial flux of 70-kilodalton dextran, 4-kilodalton dextran, or creatinine across *C parvum*--infected compared with uninfected monolayers. The only probe identified as corresponding to changes in TEER was a significant increase in the flux of ^22^Na^+^ ([Figure 7](#fig7){ref-type="fig"}*A* and *B*). Moreover, in *C parvum*--infected monolayers, the mitigating effect of rHuIFN-λ3 on loss of TEER was associated similarly with a decrease in the transepithelial flux of ^22^Na^+^ ([Figure 7](#fig7){ref-type="fig"}*C* and *D*). A univariate nonlinear regression using the least-squares method was used to determine the relationship between TEER and ^22^Na^+^ conductance across all treatment groups (uninfected vs infected) and conditions (rHuIFN-λ3 vs vehicle) and identified a statistically significant, inverse relationship (correlation matrix, -0.83; *P* \< .0001) ([Figure 7](#fig7){ref-type="fig"}*E*).Figure 7**IFN-λ3 mitigates *C parvum*--induced loss of TEER by decreasing sodium permeability.** (*A*) Mucosal to serosal flux of rhodamine dextran, FITC dextran, and creatinine across uninfected control and *C parvum*--infected IPEC-J2 monolayers at the time of peak loss of TEER (24--48 hours after infection). Individual data points represent a mean flux of 2 technical replicates per monolayer and are expressed as a fold change difference from a representative uninfected monolayer for each probe. Figure contains results obtained from 1 experiment. (*B*) Serosal to mucosal flux of ^22^Na^+^ across uninfected control and *C parvum*--infected IPEC-J2 monolayers at time of peak loss of TEER (24--48 hours after infection). Individual data points represent a mean flux of 2 technical replicates per monolayer. \*\**P* \< .01, Student *t* test comparison between uninfected and *C parvum*--infected monolayers. Data are representative of 2 independent experiments. (*C*) TEER at 24 hours after infection (expressed as the percentage of the mean of 24-hour uninfected controls). \*\**P* \< .01, 1-way analysis of variance compared with uninfected and rHuIFN- λ3--treated *C parvum*--infected monolayers. Data are representative of 2 independent experiments. (*D*) Serosal to mucosal flux of ^22^Na^+^ across uninfected control and *C parvum*--infected IPEC-J2 monolayers pretreated with vehicle or 1000 U/mL of rHuIFN-λ3 for 12 hours before infection. *Bars* represent means ± SD. \*\**P* \< .01, 1-way analysis of variance compared with rHuIFN-λ3--treated uninfected and rHuIFN-λ3--treated *C parvum*--infected monolayers. Data representative of 2 independent experiments. (*E*) Correlation between TEER (Ω × cm^2^) and flux of ^22^Na^+^. n = 26 observations from 3 individual experiments and includes uninfected and *C parvum*--infected monolayers both with and without rHuIFN-λ3 pretreatment. Correlation coefficient of -0.83, *P* \< .0001.

Discussion {#sec2}
==========

By studying IEC defense strategies against *C parvum*, these studies have identified that a type III IFN, IFN-λ3, is a conserved innate mediator of epithelial defense against this significant protozoal pathogen. We examined the significance of IFN-λ3 and specific mechanisms by which IFN-λ3 influences the epithelial defense against *C parvum* using 3 different models of infection, the neonatal piglet, suckling mouse, and nontransformed porcine intestinal epithelial cell monolayers (IPEC-J2). Results of these studies show that IFN-λ3 directly promotes epithelial resistance to parasite invasion and abrogates the loss of barrier function caused by *C parvum* infection. Although there is a wealth of literature supporting the role of IFN-λ in defending mucosal sites against viral pathogens,[@bib6], [@bib7], [@bib22] few studies have suggested a broader role for IFN-λ in mucosal defense against nonviral pathogens.[@bib9], [@bib12], [@bib23] This report shows the importance of IFN-λ in epithelial defense against a protozoal infection.

*Cryptosporidium* species is a minimally invasive epithelial pathogen that can be cleared in an immunocompetent host through an immune response largely instigated by the IECs.[@bib24] Accordingly, we hypothesized that the transcriptional responses of IEC to *C parvum* in vivo would provide key insights into how a competent host effectively resolves infection. By using a piglet model that uniquely recapitulates childhood cryptosporidiosis[@bib10] and microarray analysis to quantify gene expression by IECs obtained from the ileum of control and infected animals, we identified that the prevailing transcriptional response of IECs to *C parvum* is to up-regulate gene targets of IFN signaling. In situ localization of *ISG15* mRNA to the villus IECs of *C parvum*--infected piglets supported that the IFN response was enriched within the epithelium. The translational relevance of our findings was recently supported by RNA sequencing data showing that targets of IFN also constitute the major transcriptional response of human small intestinal enteroids in infection by *C parvum*.[@bib25] Among the significantly up-regulated IFN-stimulated genes, *ISG15* is most well known for its ability to promote antiviral defense by directly disrupting viral replication, budding, and release.[@bib26], [@bib27], [@bib28], [@bib29], [@bib30] Although we know that *ISG15* is up-regulated during *Leishmania brazilensis* and *Theileria annulata* infections, we still have limited knowledge of its function in antiparasitic defense.[@bib31], [@bib32] *GBP1*, *GBP2*, and tripartite motif containing 34 also were significantly up-regulated during *C parvum* infection; these genes have known functions in promoting host defense against nonviral pathogens, including protozoa. For example, in response to *Toxoplasma*, *Salmonella typhimurium*, and *Legionella* infection of IECs, *GBP1, GBP2*, and tripartite motif family proteins are recruited to the pathogen--host interface, specifically the parasitophorous vacuole.[@bib33], [@bib34], [@bib35] Their recruitment ultimately promotes parasitophorous vacuole disruption, enhances exposure to host immune responses, and facilitates pathogen clearance.[@bib34] Because parasitophorous vacuole formation is a hallmark feature of *C parvum* interface with host IEC,[@bib36], [@bib37] it is probable that up-regulation of these particular genes represents a conserved mechanism of epithelial defense that may be similarly effective against *C parvum*.

Surprisingly, results of our microarray did not identify a concurrent increase in types I--III IFN expression to explain the IFN-stimulated gene response of piglet intestinal epithelium to *C parvum*. A similar failure to identify the source of IFN was reported for RNA sequencing data obtained from *C parvum*--infected human enteroids in which a predominant IFN-stimulated gene response also was observed and speculated to be owing to type I IFN.[@bib25] It remains unclear why IFN gene transcription was not observed by microarray in the intestinal epithelium from infected piglets. Our demonstration (by qRT-PCR) of significant IFN gene expression by *C parvum*--infected IEC monolayers in vitro and using the entire mucosa from *C parvum*--infected piglets in vivo suggests that the epithelium is sufficient but may not be the primary source for IFN synthesis in vivo. Upon investigating *C parvum*--infected piglet ileum mucosa for the source of an epithelial-targeted IFN response, we determined that type I IFN (*IFN-α* and *IFN-β*) was not up-regulated during peak infection. However, there was significantly induced expression of a novel type III IFN, *IFN-λ3* (200-fold). Mucosal expression of type II IFN (*IFN-γ*), long recognized as an indispensable immune cell--derived cytokine associated with *C parvum* infection, also was up-regulated, although to a log-fold lesser degree than *IFN-λ3*. Expression of *IFN-λ3* in response to *C parvum* infection was an unexpected finding, as was the observation at *IFN-λ3* could influence the in vivo pathogenesis of a nonviral infection. Accordingly, identification of IFN-λ3 expression in cryptosporidiosis is a remarkable finding. Until recently, IFN-λ was considered to be largely redundant to the cellular effects of type I IFN. However, it is now recognized that IFN-λ receptors are selectively expressed by IEC, resulting in an epithelial-targeted mucosal immune response that plays a decisive role in the clearance of epitheliotropic viruses such as rotavirus, norovirus, and reovirus.[@bib6], [@bib7], [@bib22], [@bib38], [@bib39], [@bib40], [@bib41] In light of this knowledge, our findings suggest that *C parvum* likewise stimulates an epithelial targeted IFN response that is mediated, at least in part, by IFN-λ3.

To test a hypothesis that IFN-λ3 contributes specifically to epithelial defense against *C parvum* infection, we used a neonatal mouse model of the infection that enabled immunologic manipulation of IFN-λ signaling. The use of IFN-λR1 knockout mice was considered a superior approach for these studies, however, their use was repeatedly precluded by a prescreening diagnosis of norovirus infection.[@bib42] In mice, norovirus stimulates a type III IFN response that is critical for mediating viral clearance[@bib6] and we expected this would confound interpretation of this study. Consequently, we obtained pregnant C57BL/6 wild-type mice that were established to be specific pathogen-free from murine norovirus as well as other common, and potentially confounding, gastrointestinal co-infections. We subsequently infected the neonatal mouse pups with *C parvum* and confirmed conserved up-regulation of IFN-λ3 during peak infection. We then infected pups with or without pre-infection systemic immunoneutralization of IFN-λ2/3. Compared with mice treated with an isotype control antibody, mice receiving anti-mouse IFN-λ2/3 immunoneutralizing antibody harbored a significantly larger number of epithelial parasites, developed more severe villous blunting and crypt hyperplasia, and were more likely to shed *C parvum* and for a longer period of time. These findings strongly support a significant and specific influence of IFN-λ in promoting epithelial defense and possibly resolution of *C parvum* infection.

In response to viral pathogens, IECs are not only a target of IFN-λ, but also serve as a significant source of the cytokine.[@bib22], [@bib41] By using porcine IEC monolayers as a reductionist model of the intestinal epithelium, we identified that *C parvum* infection alone is sufficient to induce endogenous IFN-λ3 expression and induction of ISG15 by IECs. Paracrine stimulation of ISG15 gene expression by IFN-λ3 was supported by the ability of exogenous rHuIFN-λ3 to similarly stimulate an IEC ISG15 response in the absence of *C parvum*. Infected IECs did not up-regulate IFN-γ, most likely because immune cells and not IECs are considered the predominant sources of IFN-γ in vivo.[@bib43] The only other IFN induced by *C parvum*--infected IECs in the time frame of these studies was the type I IFN: *IFN-β*. Others have similarly shown expression of type I IFN (*IFN-α* or *IFN-β*) by *C parvum*--infected IECs, but did not examine expression of *IFN-λ*.[@bib44] It is known that pretreatment of IECs with type I IFN inhibits *C parvum* development and neonatal mice treated with anti--IFN-α/β neutralizing antibodies have more severe *C parvum* infection.[@bib44] Accordingly, we did not examine the responsiveness of our IEC monolayers to treatment with exogenous type I IFN and it is likely that endogenously produced IFN-β also contributed to the *ISG15* response observed in our *C parvum*--infected IECs. Although type I IFN and IFN-λ have distinct receptor types, both stimulate the same intracellular signaling pathway (signal transducer and activator of transcription 1/2), which results in indistinguishable overlap in target gene expression. Therefore, results of these studies do not negate an important role of type I IFN but identify a novel and significant impact of type III IFN (IFN-λ3) in epithelial defense against *C parvum* infection. Many studies provide additional context for understanding the differential influence of type I and type III IFN, at least as it pertains to viral infection. For example, restriction of the IFN-λ receptor to IECs in vivo targets the effect of IFN-λ to the epithelium, whereas type I IFN has a ubiquitous receptor expression. Recent studies using enteroid cultures have suggested that epithelial cells may up-regulate both type I and type III IFNs in response to viral infection, but only translate and secrete type III IFN.[@bib45] Therefore, recognition that *C parvum* induces IFN-λ3 gene expression and that epithelial defense mechanisms are dependent on IFN-λ3 has important implications for further development of targeted therapies for the infection.

In the present study, IECs primed with IFN-λ3 were more resistant to infection by *C parvum*. The principle mechanism of IFN-λ3 action was to impair parasite invasion of enterocytes. This finding substantiates our observation of an increased burden of epithelial parasitism in mouse pups treated with IFN-λ2/3 immunoneutralizing antibodies. Once *C parvum* invaded the IEC cells, however, there were no appreciable changes in the ability of the parasites to develop intracellularly. Enterocyte resistance to *C parvum* also has been described in monolayers pretreated with types I and II IFN, however, given preferential targeting of intestinal epithelial cells by IFN-λ in vivo,[@bib7], [@bib22] our results likely have more biological relevance. In addition to enhanced resistance to infection by *C parvum*, IECs primed with IFN-λ3 were protected from decreases in barrier function resulting from the infection. Barrier protective effects of IFN-λ at the level of the blood-brain barrier, as well as in polarized T84 cells (colonic adenocarcinoma), have been observed in the presence and absence of viral or bacterial injury.[@bib8], [@bib9] In contrast, we observed IFN-λ3's barrier mitigating effect only in the face of *C parvum* infection. The reason for this observational difference is unknown. Regardless of IFN-λ3's role in influencing IEC barrier function at homeostasis, our findings now provide further proof that IFN-λ3 defends IECs against pathogen-induced barrier disruption. We probed the paracellular pathway by which *C parvum* and IFN-λ3 influenced the TEER of IEC monolayers and isolated the barrier defect to a corresponding change in flux of ^22^Na^+^, indicating the characteristics of an ion/charge selective pathway. Interestingly, IFN-λ has been shown to promote barrier function in the blood-brain barrier by enhancing junctional localization of the tight junctional protein claudin-5.[@bib8] Furthermore, overexpression of claudin-5 in Madin-Darby Bovine Kidney Cells (MDBK) epithelial cells led to an increase in TEER and selectively decreased the relative permeability of Na^+^ ions.[@bib46] In light of these findings, the influence of IFN-λ3 on the expression and localization of claudin-5 during *C parvum* infection is worth investigating.

In closing, these studies have identified a novel mechanism for intestinal epithelial defense against *C parvum* involving IFN-λ3. In our studies, IFN-λ3 promoted epithelial defense by not only limiting parasite invasion but also promoting intestinal epithelial barrier function. These findings broaden the scope and depth of our current understanding of IFN-λ's significance for epithelial defense and provide a mechanistic focus for development of targeted therapies for *Cryptosporidium* species infection.

Materials and Methods {#sec3}
=====================

Piglet Model of Cryptosporidiosis {#sec3.1}
---------------------------------

One-day-old piglets were obtained from the College of Agriculture and Life Sciences. Piglets were transported to the College of Veterinary Medicine and placed into infected or control Biosafety Level 2 isolation facilities and fed a liquid diet (nonmedicated Advance Liqui-Wean; Milk Specialties, Dundee, IL) hourly by an automated delivery device. An inoculum of 10^8^ *C parvum* oocysts (Bunchgrass Farms, Deary, ID) was given to piglets by orogastric tube at 3 days of age and samples were collected at peak infection 3--5 days later. Before sample collection, each piglet was anesthetized with ketamine (15 mg/kg) and xylazine (0.5 mg/kg) given intramuscularly and they were killed using sodium pentobarbital (200 mg/kg). Sections of ileum mucosa then were collected for epithelial exfoliation (microarray), fixation in 10% neutral buffered formalin (histology), or embedded in optimal cutting temperature media and frozen in liquid nitrogen (in situ hybridization). All studies were approved by the Institutional Animal Care and Use Committee of North Carolina State University.

RNA Microarray {#sec3.2}
--------------

The intestinal epithelium was exfoliated from freshly obtained sections of uninfected control (n = 4) and *C parvum*--infected (n = 8) porcine ileum mucosa in an oxygenated citrate-phosphate buffer containing 2.5 mmol/L glucose, 10 mmol/L EDTA, 137 mmol/L NaCl, 2.7 mmol/L KCl, 8.0 mmol/L Na~2~HPO~4~, and 1.5 mmol/L KH~2~PO~4~ (pH 7.4) for 20 minutes at 37°C. To dislodge epithelial cells from the lamina propria, submerged mucosa was grasped with forceps, which then were vibrated by contact with a vortex. Removal of epithelial cells was confirmed by histologic examination. The epithelial cells were pelleted by centrifugation at 200*g* for 10 minutes at 4°C. Each fraction was placed in 10 volumes of RNAlater or RLT buffer containing mercaptoethanol (Qiagen, Valencia, CA) and stored at -80°C.

Total RNA was isolated and treated with DNase (RNeasy Mini Kit; Qiagen, Germantown, MD) according to the manufacturer\'s instructions. RNA quantity and quality were determined by capillary electrophoresis (Agilent 2100 Bioanalyzer; Agilent Technologies, Santa Clara, CA). Total RNA (2 μg) was converted into complementary DNA (cDNA) using Reverse Transcriptase (Enzo Biosciences, Farmingdale, NY) and a modified oligo(dT)24 primer that contains T7 promoter sequences (GenSet, Boulder, CO). After first-strand synthesis, residual RNA was degraded by the addition of RNaseH and a double-stranded cDNA molecule was generated using DNA polymerase I and DNA ligase. The cDNA then was purified and concentrated using a phenol:chloroform extraction followed by ethanol precipitation. The cDNA products were incubated with T7 RNA polymerase and biotinylated ribonucleotides using an In Vitro Transcription kit (Affymetrix, Santa Clara, CA). The resultant complementary RNA product was purified using an RNeasy column (Qiagen) and quantified with a spectrophotometer. The complementary RNA target (20 μg) was incubated at 94°C for 35 minutes in fragmentation buffer (Tris, MgOAc, KOAc). The fragmented complementary RNA was diluted in hybridization buffer (2 N -morpholino-ethanesulfonic acid, NaCl, EDTA, Tween 20, herring sperm DNA, acetylated bovine serum albumin) containing biotin-labeled OligoB2 and Eukaryotic Hybridization Controls (Affymetrix). The hybridization cocktail was denatured at 99°C for 5 minutes, incubated at 45°C for 5 minutes, and then injected into an Affymetrix Porcine GeneChip cartridge. The GeneChip array was incubated at 42°C for at least 16 hours in a rotating oven at 60 rpm. GeneChips were washed 91 times with a series of nonstringent (25°C) and stringent (50°C) solutions containing variable amounts of MES, Tween20, and Sodium Chloride-Sodium Phosphate-EDTA. The microarrays then were stained with streptavidin phycoerythrin and the fluorescent signal was amplified using a biotinylated antibody solution. Fluorescent images were detected in a GeneChip Scanner 3000 and expression data were extracted using the GeneChip Command Console Software (AGCC) v 2.0 or later (Affymetrix).

Fluorophore-labeled cDNA was prepared and hybridized to Affymetrix Porcine GeneChip microarrays (20,201 genes) by a commercial laboratory (Expression Analysis, Durham, NC). All GeneChips were scaled to a median intensity setting of 500. The arrays were first normalized with a Loess normalization technique using JMP Genomics (SAS, Cary, NC), and analysis of gene expression changes was performed via analysis of variance. False-discovery rates were calculated according to the methods of Storey[@bib47] and a false-discovery threshold of 0.05 was adopted to identify differentially expressed genes. A 2-fold change in gene expression from the control cells was the minimum change to be considered for further analysis. Lists of differentially expressed genes were analyzed further using Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, CA). Determination of enriched biological processes was determined by entering up-regulated genes into the Protein ANalysis THrough Evolutionary Relationships (PANTHER) database.

Quantitative Histopathology {#sec3.3}
---------------------------

Formalin-fixed sections of ileum mucosa were paraffin-embedded, sectioned at a thickness of 5 μm, and stained with H&E. For each piglet, the average crypt depth and villus height was calculated from measurements of 5 well-oriented, villus-crypt units using a brightfield microscope and ocular micrometer. The percentage of infection was determined by dividing the number of infected villus enterocytes by the total number of villus enterocytes.

Fluorescence In Situ Hybridization {#sec3.4}
----------------------------------

Custom probes designed for hybridization with porcine *ISG15* were purchased (Affymetrix). Probes were hybridized to formalin-fixed and paraffin-embedded, 5-μm sections of porcine ileum mucosa (ViewRNA in situ hybridization kit, catalog QVC0001; Affymetrix) using the manufacturer protocol for 1-plex hybridization. Slides were deparaffinized using xylene (30 minutes) and heat and protease K pretreated (10 and 30 minutes, respectively). After initial hybridization, signal amplification was performed using pre-amplifier and amplifier probes using a slide hybridization and denaturation system (ThermoBrite, catalog 23-021-580; Leica Microsystems, Wetzlar, Germany). To detect the ISG15 target, slides were incubated with fast-red chromagen (1:30 dilution for 45 minutes), washed, and coverslipped using mounting media containing DAPI (VECTASHIED antifade mounting medium with DAPI, catalog H-1200-10; Vector Labs, Burlingame, CA). Slides were imaged using a fluorescence microscope (Leica DB 5000B with LASX software; Leica Microsystems). Rat ubiquitin probes were hybridized to formalin-fixed and paraffin-embedded rat kidney slides as a hybridization control.

Immunoneutralization of IFN-λ2/3 in Neonatal Mouse Pups Infected With Cryptosporidiosis {#sec3.5}
---------------------------------------------------------------------------------------

Conventional (specific pathogen-free, which includes common gastrointestinal pathogens such as norovirus, reovirus, rotavirus, *Citrobacter rodentium*, *Salmonella*, *Helicobacter*, and *Giardia*) C57BL/6 pregnant dams (embryonic days 13--15) were purchased (Charles River Laboratories, Durham, NC) and housed in accordance with Biosafety Level 2 guidelines. Litters were assigned to 1 of 4 treatment groups, as follows: (1) uninfected control mice treated with isotype (rat IgG) antibody, (2) uninfected control mice treated with rat anti-mouse IFN-λ2/3 immunoneutralizing antibody, (3) *C parvum*--infected mice treated with isotype (rat IgG) antibody, and (4) *C parvum*--infected mice treated with rat anti-mouse IFN-λ2/3 immunoneutralizing antibody. Each mouse pup was administered either 15 μg of IFN-λ2/3 neutralizing antibody (Monoclonal Rat IgG~2B~ clone 244716, catalog MAB17892; R&D Systems, Minneapolis, MN) or 15 μg of rat IgG isotype control antibody (Monoclonal Rat IgG~2B~ clone 141945, catalog MAB0061; R&D Systems) by intraperitoneal injection on days -1, 0, and 3 of infection. The dose was calculated based on the quantity required to achieve 100% immunoneutralization of IFN-λ2/3 in vitro (ED100) and estimated blood volume of pups on day 10 of infection (day 14 of life). Pups were infected orogastrically with 2 × 10^5^ oocysts of *C parvum* in 10 μL of phosphate-buffered saline (PBS) using a 25-mm, plastic gavage needle (Petsurgical, Westlake Village, CA). During the 10-day course of infection, pups were weighed daily. Pups were euthanized using isofluorane anesthesia followed by decapitation. Immediately after euthanasia the gastrointestinal tract was removed from the abdominal cavity. A section of the small intestine extending from the distal jejunum to the proximal ileum was snap-frozen for RNA extraction. The ileocecocolic region of the intestine was formalin-fixed and paraffin-embedded, sectioned at a thickness of 5 μm, and stained with H&E before quantifying the burden of epithelial infection and histomorphometry using light microscopy (Accu-scope 3025; Olympus Corporation, Tokyo, Japan). Digital images of well-oriented individual villus-crypt units were captured (cellSens software; Olympus) at a magnification of 400×. The total number of epithelial cell--associated *Cryptosporidium* parasites were counted for each of 10 well-oriented villus-crypt units. Villus height and crypt depth measurements were obtained from each villus-crypt unit using ImageJ software (National Institutes of Health, Bethesda, MD).

RNA Extraction and Real-Time PCR Analysis {#sec3.6}
-----------------------------------------

For RNA extraction from tissue, snap-frozen samples of ileum mucosa (piglets) or total distal jejunum/proximal ileum (mice) were placed in ice-cold lysis buffer, homogenized, and sonicated to disrupt the tissue. For RNA extraction from cell culture monolayers, media was removed and monolayers were washed 3 times with PBS, lysis buffer was applied directly to monolayers, and cells were scraped off inserts with a sterile cell lifter. Total RNA was extracted using a commercial kit (Ambion PureLink Mini kit, catalog 12183025; Thermo Fisher Scientific, Raleigh, NC) including DNAse treatment (Turbo DNA free kit, catalog AM1907; Thermo Fischer, Waltham, MA). RNA concentration and purity were quantified by spectrophotometry (Nanodrop ND-1000; Thermo Fisher Scientific, Waltham, MA). A total of 1 μg of total RNA was converted to single-stranded cDNA by reverse transcription (high-capacity cDNA reverse transcription kit, catalog 4368814; Thermo Fisher Scientific, Waltham, MA). After reverse transcription, quantitative PCR was performed in a 15 μL reaction volume with 50 nmol/L of each primer, 60 ng cDNA, and 2 × SYBR green Mastermix (catalog 04707516001; Roche Diagnostics, Basel, Switzerland) using a Roche Lightcycler 480 for 50 cycles at 95°C for 15 seconds and 60°C for 1 minute after an initial incubation for 10 minutes at 95°C. PCR products were additionally examined after electrophoresis in 1.5% agarose gels stained with GelRed DNA stain (catalog 41003; Biotium, Freemont, CA). The identity of amplicons was confirmed by expected size, melting temperature, and commercial sequencing (GeneWiz, South Plainfied, NJ). Expression of the following genes were targeted: *C parvum* glycoprotein 40/15 (*Cp* *gp40/15*) porcine *IFN-α* (all isoforms, poIFN-α-all), porcine IFN-α isoforms 7/11 (*poIFN-α-7/11*), porcine IFN α isoform 9 (*poIFN-α9*), porcine IFN-β (*poIFN-β*), porcine IFN-γ (*poIFN-γ*), porcine IFN-λ1 (*poIFN-λ1*), porcine IFN-λ3 (*poIFN-λ3*), porcine IFN-λ4 (*poIFN-λ4*), porcine IFN-λ--receptor 1 (*poIFN-λR1*), porcine ISG15 (*poISG15*), murine IFN-λ2/3 (*muIFN-λ2/3*), murine IFN-β (*muIFN-β*), and murine ISG15 (*muISG15*). All primers were purchased from Integrated DNA technologies (Skokie, IL). Primer sequence data and references of origin are shown in [Table 1](#tbl1){ref-type="table"}. Primers were designed either by the authors or as previously described.Table 1Specific Primer Sequences and Sources Used in Real-Time RT-PCR and Their Resulting Amplification Product Sizes and Melting TemperaturesmRNAForward, 5' to 3'Reverse, 5' to 3'Product sizeMelting temperature, C°Reference***Cp* gp40/15**TCATTTGTAATGTGGTTCGGAGAAAGGGTAAAGGCAAACAAATCG32682.5--83.0[@bib48]**Porcine-IFNα (all)**GGCTCTGGTGCATGAGATGCCAGCCAGGATGGAGTCCTCC19788.45--88.80[@bib15]**Porcine-IFNα 7/11**GGGACTTTGGATCCCCTCATGTGGAGGAAGAGAAGGATG36989.0--89.5[@bib49]**Porcine-IFNα9**GTGCTGCTCAGCTGCAAGAGTCCTCCTCCAGCAGGGGC38487.5--88.5[@bib49]**Porcine-IFNβ**ATGTCAGAAGCTCCTGGGACAGTTAGGTCATCCATCTGCCCATCAAGT24682.20--82.70[@bib15]**Porcine-IFNγ**GTTTTTCTGGCTCTTACTGCCTTCCGCTTTCTTAGGTTAG41086.3--87.0[@bib50]**Porcine-IFNλ1**ACATCCACGTCGAACTTCAGGCTTTCAGATGTGCAAGTCTCCACTGGT20987.5--88.0[@bib49]**Porcine-IFNλ3**AAGAGGGCCAAGGATGCCTTTGAAAGGCGGAAGAGGTTGAACATGACA37492.9--93.3[@bib49]**Porcine-IFNλ4**GTCACAGAGCTGACTCGCCTTCACAGACAAGGCCCCGAAT11089.2--89.5Authors**Porcine-ISG15**GATGCTGGGAGGCAAGGACAGGATGCTCAGTGGGTCTCT22990.0--90.3Authors**Porcine-IFNλR1**CGGTGGCAAAGAGTGAAAATGATCTCCTCTGTCCGGGTGA24986.7--86.8Authors**Porcine-Cyclophilin**CCGTCGATGGCGAGCCCCCCGTATGCTTCAGGATAAAA25082.5--84.5[@bib51]**Murine-IFNL2/3**AGCTGCAGGCCTTCAAAAAGTGGGAGTGAATGTGGCTCAG24488.5--89.1[@bib7]**Murine-ISG15**GAGCTAGAGCCTGCAGCAATTTCTGGGCAATCTGCTTCTT12284.3--84.5[@bib7]**Murine-IFNβ**GGAGATGACGGAGAAGATGCCCCAGTGCTGGAGAAATTGT10379.9--80.6[@bib52]**Murine-GAPDH**TGCACCACCAACTGCTTAGCGGCATGGACTGTGGTCATGAG8784.2--84.4[@bib7][^1]

All qPCR reactions were performed in technical triplicate and averaged to generate a single cycle threshold value (Ct). Each reaction was confirmed to generate a sigmoidal amplification plot and a single melt curve at the target temperature to be considered a positive amplification. Each sample underwent additional amplification of a housekeeping gene, also performed in triplicate and averaged, for use in generating a normalized Ct value (ΔCt). For porcine-origin samples, cyclophilin was used as the housekeeping gene. For murine-origin samples, glyceraldehyde-3-phosphate dehydrogenase was used as the housekeeping gene. To compare fold-change differences in expression between, as well as within, experimental conditions, a representative sample was chosen from the comparator condition (eg, uninfected, vehicle-treated, or initial time point group) and used as a reference to calculate a ΔΔCt for each sample. Fold-change differences in gene expression between samples and the comparator were calculated using the 2^-ΔΔCt^ method. This approach was used because it enables an objective look at the variability between samples in the control/reference group and works well for studies in which observations between groups are unpaired.

Polarized Intestinal Epithelial Cell Culture Response to Cryptosporidiosis {#sec3.7}
--------------------------------------------------------------------------

Nontransformed porcine jejunal epithelial cells (IPEC-J2) were grown in co-culture media that included Dulbecco's minimal essential medium:nutrient mixture F-12 (with L-glutamine and 15 mmol/L HEPES, catalog 10-092-CM; Corning, Corning, NY) supplemented with 5 μg/mL each of insulin, transferrin, and selenium (ITS Premix universal culture supplement, catalog 354350; Corning), epidermal growth factor (5 ng/mL, catalog 354052; Corning), penicillin (50,000 IU/mL), streptomycin (50,000 mg/mL) (100× penicillin-streptomycin solution, catalog 30002CI; Corning), and 5% porcine serum (catalog 26250084; Thermo Fischer, Waltham, MA), and incubated at 37°C in 5% CO~2~. Cells were seeded onto permeable polycarbonate filters (0.4-μm pore size, either 0.6 cm^2^ or 4.67cm^2^; catalog PIHP01250 and PIHP03050, respectively; Millipore Sigma, Burlington, MA) and cultured until confluent (TEER, ≥2000 Ω × 0.6 cm^2^ or ≥1300 Ω × 4.67 cm^2^). TEER was measured using an EVOM2 epithelial voltohmmeter with chopstick electrodes (World Precision Instruments, Sarasota, FL). For immunofluorescence assessment of *C parvum* burden, IPEC-J2 cells were seeded onto 8-well chamber slides (Nunc Lab-Tek II, catalog 154534; Thermo Fisher, Waltham, MA) and grown to confluence over a period of 3--4 days before use. IPEC-J2 cells were used at passages 38--50. Media was changed every 3--4 days.

Infection of IPEC-J2 Cells With *C parvum* {#sec3.8}
------------------------------------------

*C parvum* oocysts (Bunchgrass Farms) were pelleted by centrifugation (13,000 × g for 3 minutes) and treated with 10 mmol/L HCl (catalog 13-1700 SAJ; Millipore Sigma) in PBS for 60 minutes in a 37°C water bath The oocysts then were pelleted by centrifugation to remove the HCl, reconstituted with 0.2 mmol/L sodium taurodeoxycholate and 22 mmol/L NaHCO~3~ (catalog T0875 and S6014, respectively; Millipore Sigma) in PBS, and incubated for 30 minutes in a 37°C water bath to excyst infective sporozoites. The excysted oocysts were centrifuged and reconstituted in IPEC-J2 culture media. The number of excysted oocysts was counted using a hemacytometer to establish a final concentration of excysted oocysts. A multiplicity of infection of 2:1 of excysted oocysts to IPEC-J2 cells was used to inoculate monolayers. Based on established counts of approximately 5 × 10^5^ IPEC-J2 cells per 30 mm (4.2 cm^2^) insert at confluence, each monolayer was infected with 1 × 10^6^ excysted oocysts.

Stimulation of IPEC-J2 Cells With IFN-λ3 {#sec3.9}
----------------------------------------

Monolayers of IPEC-J2 cells were treated at the time of confluence with 100--2500 U/mL of rHuIFN-λ3 in PBS (catalog 11730-1; PBL Assay Science, Piscataway, NJ). For determination of effects on *C parvum* infection, cells were pretreated with rHuIFN-λ3 beginning 12 hours before infection of the monolayer and sustained within the culture medium throughout the course of infection.

Crystal Violet Cytotoxicity Assay {#sec3.10}
---------------------------------

Uninfected control and *C parvum*--infected IPEC-J2 cells were grown to confluence on 24-well polystyrene plates. At designated postinfection time intervals, epithelial monolayers were gently washed with PBS to remove detached epithelial cells, fixed with 2% paraformaldehyde in PBS for 15 minutes at room temperature, washed with Hank's balanced salt solution, and stained with 100 μL of 0.13% crystal violet solution dissolved in a 5:2 (vol/vol) ethanol-paraformaldehyde solution. Monolayers were washed twice with dH~2~0 and allowed to air dry. Stained cells were solubilized in 100 μL 1% sodium dodecyl sulfate in 50% ethanol and transferred to 96-well plates. The intensity of staining was quantified using a spectrophotometer at a wavelength of 570 nmol/L, with a reference wavelength of 650 nmol/L to account for optical interference.

Epithelial Permeability Assays {#sec3.11}
------------------------------

IPEC-J2 monolayers were grown to confluence on 12-mm diameter, 0.4-μm pore size polycarbonate filters. A subset of monolayers was infected with *C parvum*, and the permeability of uninfected control and *C parvum*--infected monolayers was measured at 24 and 48 hours after infection by concurrent transepithelial passage of 3 permeability probes: creatinine, fluorescein isothiocyanate--4 kilodalton dextran, and rhodamine--70 kilodalton dextran (catalog C4255, 46944, and R9379; Millipore Sigma). Probes were prepared in cell culture media at a final concentration of 11 mg/mL. At the beginning of each flux period, 100 μL of the flux solution was added to the apical side of each insert to give a final volume and concentration of 500 μL and 2.2 mg/mL, respectively. After 2 hours of incubation, basolateral recovery of each probe was measured in a plate reader (Synergy HT; BioTek, Winooski, VT) using freshly prepared standards. Fluorescence of fluorescein and rhodamine B were measured at 490 and 555 nm using emission wavelengths of 520 and 585 nm, respectively. Creatinine was measured separately using a colorimetric assay (catalog MAK080; Millipore Sigma).

Epithelial Permeability to ^22^Na^+^ {#sec3.12}
------------------------------------

Basolateral to apical isotopic flux studies of ^22^Na^+^ (1 μCi/mL, catalog NEZ081100UC; Perkin Elmer, Waltham, MA) was performed in uninfected control and *C parvum*--infected IPEC-J2 monolayers with or without pretreatment with 1000 U/mL of rHuIFN-λ3 12 hours before infection. Barrier function (TEER) was measured at time points of 6, 12, 24, 36, and 48 hours over the course of infection. At 24 hours after infection, a 50-μL aliquot of ^22^Na+ working stock was added to a 450 μL existing volume of basolateral media. After a flux period of 2 hours, paired 200-μL samples were obtained from both the apical and basolateral compartments. Sample emissions were counted using a gamma counter (Wallac Wizard 1470-020; Perkin Elmer) and basolateral to apical flux of Na^+^ was expressed as μEq × cm^2^ per hour.

Determination of IFN-λ3 Effects on *C parvum* Burden and Intracellular Development in Epithelial Monolayers {#sec3.13}
-----------------------------------------------------------------------------------------------------------

IPEC-J2 cells were cultured to confluency (3--4 days) in 8-well chamber slides and treated or not with 1000 U/mL of rHuIFN-λ3 for 12 hours before infection with *C parvum* or vehicle (0.1% bovine serum albumin in PBS). At 4, 6, 12, 24, and 48 hours after infection, slides were washed 3 times with PBS and fixed with 4% paraformaldehyde for 10 minutes at room temperature. After fixation, cells were washed 3 times with PBS, incubated in a blocking solution of 1% bovine serum albumin in PBS for 30 minutes, and permeabilized for 5 minutes with 0.5% Triton X-100 (Millipore Sigma) in PBS at room temperature and then washed once with PBS for 30 seconds. To visualize epithelial invasion sites of *C parvum* organisms, slides were incubated with a red fluorescent phalloidin conjugate (acti-stain 555 phalloidin, catalog PHDH1-A; Cytoskeleton, Inc, Denver, CO) at a concentration of 100 nmol/L at room temperature for 30 minutes. The monolayers then were washed 3 times with PBS. For simultaneous visualization of *C parvum* organisms, monolayers subsequently were incubated at room temperature for 45 minutes with a FITC-labeled rat anti-*Cryptosporidium* parvum polyclonal antibody (1× Sporo-Glo, catalog A600FLR; Waterborne, Inc, New Orleans, LA). Finally, monolayers were washed 3 times with PBS, partially air-dried, and then cover slipped with mounting media containing DAPI (Vectashield antifade mounting medium with DAPI; Vector Labs). Monolayers were imaged using a fluorescence microscope (Leica DMB5000B with LASX software; Leica Microsystems). Quantification of *C parvum* burden was determined by counting the total number of FITC-labeled parasites that also were associated with characteristic F-actin invasion sites within ten 400× fields per infected well. For characterization of life stages present, attached parasites were measured using LASX software (Leica Microsystems) in 5 individual 1000× fields per well and categorized as either sporozoite (∼4 × 1 μm, elongate, eccentric F-actin invasion site), early trophozoite (≤1 × 1 to 2 × 2 μm, round, centralized F-actin invasion site), trophozoite (2 ×2 to 3 × 3 μm, round, centralized F-actin invasion site), or meront (\<3 × 3 cm, round, often with multiple nuclei visible).

Data Analysis {#sec3.14}
-------------

Data were tested for normality using a Shapiro--Wilk test and equal variance using Levene's median test. (SigmaStat; Jandel Scientific, San Rafael, CA). Parametric data were analyzed using the Student *t* test and 1-way analysis of variance. Nonparametric data were analyzed using Kruskal--Wallis rank-sum tests. Differences in the proportion of observations between groups was analyzed using chi-square analysis of contingency tables using a Yates continuity correction. Descriptive data are represented as means ± SD. For all analyses, *P* ≤ .05 was considered significant. All authors had access to the study data and reviewed and approved the final manuscript.
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[^1]: GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
